Arcturus Therapeutics's total assets for Q3 2025 were $282.34M, a decrease of -8.71% from the previous quarter. ARCT total liabilities were $57.78M for the fiscal quarter, a -26.12% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.